Stock 6540 JHL BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company JHL Biotech, Inc.

Equities

6540

KYG7863U1076

Pharmaceuticals

Business Summary

JHL BIOTECH, INC. is a Taiwan-based company principally engaged in development and manufacturing of biopharmaceuticals. The Company provides cell line cloning, process development, and manufacturing capabilities and services to emerging and established biopharmaceutical companies seeking to collaboratively develop, manufacture and commercialize biologics.

Managers

Managers TitleAgeSince
Raco Ivan Jordanov CEO
 Chief Executive Officer 76 12-06-11
Ellis Chu DFI
 Director of Finance/CFO - 18-04-30
Cui WeiDong CTO
 Chief Tech/Sci/R&D Officer - -
Rong Chen CTO
 Chief Tech/Sci/R&D Officer - 17-12-31
DJ Lin LAW
 General Counsel - 17-03-30
Jill Liu AUD
 Comptroller/Controller/Auditor - 14-12-31
Peter Pang LAW
 General Counsel - 14-10-31
Nick Kotlarski PRN
 Corporate Officer/Principal - -
Andreas Nechansky PRN
 Corporate Officer/Principal - -
Max Chan AUD
 Comptroller/Controller/Auditor 56 15-10-19

Members of the board

Members of the board TitleAgeSince
Zuie Chin Huang CHM
 Chairman 58 12-12-16
Bryant Fong BRD
 Director/Board Member 51 12-12-16
Yi Hsiung Chen BRD
 Director/Board Member - 15-05-13
Ying Du BRD
 Director/Board Member 59 12-12-16
Raco Ivan Jordanov CEO
 Chief Executive Officer 76 12-06-11
Rose Lin FOU
 Founder - 12-06-11
Jun Wu BRD
 Director/Board Member - 15-05-13
Chia Lin Wang BRD
 Director/Board Member - 15-05-13
Fang Hsi Teng BRD
 Director/Board Member - 15-05-13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 220,403,607 220,403,607 ( 100.00 %) 0 100.00 %

Company contact information

Eden Biologics, Inc.

5/F, No.18, Section 2 Shengyi Road

302, Zhubei

+

http://www.jhlbiotech.com
address JHL Biotech, Inc.(6540)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sector Biopharmaceuticals

1st Jan change Capi.
CSL LIMITED Stock CSL Limited
-1.85% 89.87B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-3.95% 37.57B
UCB Stock UCB
+62.29% 26.47B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-22.14% 14.25B
INCYTE CORPORATION Stock Incyte Corporation
-7.96% 12.99B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.33% 11.93B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-46.33% 10.84B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+4.64% 9.11B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-19.53% 7.32B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 6540 Stock
  4. Company JHL Biotech, Inc.